A carregar...
Interferon-β treatment for multiple sclerosis
Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment. Numerous large-scale clinical trials in early,...
Na minha lista:
| Publicado no: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479675/ https://ncbi.nlm.nih.gov/pubmed/17920544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2007.07.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|